Business Context and Reporting Period
Company: BiomX Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 28, 2026
Reporting Period: Event-specific report regarding a corporate action approved on August 25, 2026, and announced on August 28, 2026.
Key Financial Metrics
This filing is a Current Report (Form 8-K) detailing a corporate governance event and does not contain financial performance data. The filing text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The primary material change announced is a 1-for-10 reverse stock split of the Company's common stock. Key details include:
- Share Reduction: Outstanding shares will decrease from approximately 26.7 million to approximately 2.7 million.
- Authorized Shares: Reduced from 750,000,000 to 150,000,000.
- Effective Date: Expected to become effective at 12:01 a.m. Eastern Time on September 9, 2026.
- Trading: Common stock (Symbol: PHGE) is expected to begin trading on a split-adjusted basis on the NYSE American on September 9, 2026.
- Fractional Shares: No fractional shares will be issued; holders will be rounded up to the next whole share.
- Adjustments: Proportionate adjustments will be made to exercise prices and share counts for outstanding warrants, convertible instruments, and equity awards.
Guidance, Outlook, and Risks
Management Commentary: The Board of Directors fixed the split ratio at 1-for-10 via unanimous written consent. The Company expects to file the Certificate of Amendment with the Delaware Secretary of State to effect the split.
Risks and Contingencies: The filing includes forward-looking statements subject to risks and uncertainties, including:
- Timing of the filing and effectiveness of the Certificate of Amendment.
- Processing of corporate actions by the NYSE American.
- General risks described in the Company's Form 10-K for the fiscal year ended December 31, 2025, and subsequent filings.
Investor Verification Checklist
- Verify the effective time of the reverse stock split (September 9, 2026, at 12:01 a.m. ET).
- Confirm the new CUSIP number (09090D 608) for post-split trading.
- Review the treatment of fractional shares (rounding up to the next whole share).
- Check for subsequent Item 5.03 filings confirming the effectiveness of the Certificate of Amendment.
- Monitor the NYSE American for the commencement of split-adjusted trading on September 9, 2026.